Tumor-infiltrating lymphocyte therapy marks a milestone in cancer treatment
The recent approval by the U.S. Food and Drug Administration of lifileucel, the first commercial tumor-infiltrating lymphocyte (TIL) therapy for… Read More »Tumor-infiltrating lymphocyte therapy marks a milestone in cancer treatment